The 5-Second Trick For pentobarbital sodium drug class
The 5-Second Trick For pentobarbital sodium drug class
Blog Article
pentobarbital decreases effects of hemin by pharmacodynamic antagonism. Use Warning/Keep an eye on. Drugs that boost delta-aminolevulinic acid synthetase might minimize hemin effect.
pentobarbital will lower the level or effect of vinorelbine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Importance Unidentified.
Due to the fact this kind of clients may be much less aware about particular with the milder adverse effects of barbiturates, the incidence of such reactions may be somewhat better in totally ambulatory sufferers.
pentobarbital will lessen the extent or effect of lumacaftor/ivacaftor by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated.
Phenytoin, sodium valproate, valproic acid: The effect of barbiturates over the metabolism of phenytoin seems to become variable. Some investigators report an accelerating effect, although others report no effect. Since the effect of barbiturates around the metabolism of phenytoin is not predictable, phenytoin and barbiturate blood amounts need to be monitored much more click here often if these drugs are offered concurrently.
pentobarbital will minimize the extent or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Observe. Prevent mixture in pulmonary HTN sufferers. For clients with ED, observe response to tadalafil thoroughly as a result of possible for decreased effectiveness.
Monoamine oxidase inhibitors (MAOI): MAOI prolong the effects of barbiturates possibly because metabolism from the barbiturate is inhibited.
pentobarbital will minimize the level or effect of estropipate by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch.
pentobarbital will lower the level or effect of pitolisant by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Check Closely. Pitolisant exposure is diminished by 50% if coadministered with strong CYP3A4 inducers.
pentobarbital will lessen the extent or effect of efavirenz by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Small/Significance Not known.
Contraindicated (1)pentobarbital will lower the extent or effect of lorlatinib by influencing hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will lessen the extent or effect of tipranavir by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check.
pentobarbital will lessen the extent or effect of conivaptan by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check.
pentobarbital will minimize the extent or effect of capivasertib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Stay clear of or Use Alternate Drug. Potent or moderate CYP3A inducers reduce capivasertib exposure, which can cut down efficacy.